Arcus Biosciences, Inc. (RCUS) Presents at Morgan Stanley 23rd Conference Transcript
Group 1 - The company is focusing on strategic priorities as it heads into 2026, with an emphasis on pipeline development [2] - Key executives from the company, including the COO and CMO, are present to discuss the company's direction and initiatives [1] - The discussion aims to provide insights into the company's strategic focus and operational goals moving forward [2]